Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.

Maturitas - 1 Jan 2014

Tea Muy-Kheng M, Kroiss Regina, Muhr Daniela, Fuerhauser-Rappaport Christine, Oefner Peter, Wagner Teresa M, Singer Christian F

Abstract excerpt

BACKGROUND: Mutations in brca1 and 2 genes lead to a significant increase in the lifetime risk of developing breast (BC) and ovarian cancer (OC). There are indications that birth cohort can influence the cancer risk in brca1 mutation carriers. Therefore, we investigated the risks for BC and OC associated with brca2 mutations in a cohort of female mutation carriers of a genetically heterogeneous Central European...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Europe

Share to Genes, BRCA2

Share to Kaplan-Meier Estimate

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 24156927
DOI: 10.1016/j.maturitas.2013.09.012

Genes

BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.PMID 24156927Read ↗

Inverse birth cohort effects in ovarian cancer: Increasing risk in BRCA1/2 mutation carriers and decreasing risk in the general population.Semantic proximity Read ↗

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?Semantic proximity Read ↗

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.Semantic proximity Read ↗

Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.Semantic proximity Read ↗

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.Semantic proximity Read ↗

Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies.Semantic proximity Read ↗

Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers.Semantic proximity Read ↗

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Lifestyle factors across generations and early-onset breast cancer risk: Evidence from the Australian Longitudinal Study on Women’s HealthSemantic proximity Read ↗

Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.